Orthopediatrics (KIDS) Free Cash Flow (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Orthopediatrics | 394.83 Mn | 346.02 Mn | 43.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -151.77% |
| Dec 31, 2025 | 385.06% |
| Sep 30, 2025 | 75.41% |
| Jun 30, 2025 | -65.90% |
| Mar 31, 2025 | -179.55% |
| Dec 31, 2024 | 190.38% |
| Sep 30, 2024 | 8.74% |
| Jun 30, 2024 | 2.84% |
| Mar 31, 2024 | -365.50% |
| Dec 31, 2023 | 144.43% |
| Sep 30, 2023 | -11.52% |
| Jun 30, 2023 | 12.32% |
| Mar 31, 2023 | -258.06% |
| Dec 31, 2022 | 200.92% |
| Sep 30, 2022 | 46.82% |
| Jun 30, 2022 | -60.09% |
| Mar 31, 2022 | -192.47% |
| Dec 31, 2021 | 2.08% |
| Sep 30, 2021 | 72.61% |
| Jun 30, 2021 | -129.44% |
| Mar 31, 2021 | -10.70% |
| Dec 31, 2020 | 14.96% |
| Sep 30, 2020 | 44.70% |
| Jun 30, 2020 | 17.88% |
| Mar 31, 2020 | -35.31% |
| Dec 31, 2019 | -228.93% |
| Sep 30, 2019 | 76.64% |
| Jun 30, 2019 | -24.42% |
| Mar 31, 2019 | -215.88% |
| Dec 31, 2018 | -14.79% |
| Sep 30, 2018 | 71.06% |
| Jun 30, 2018 | -2.97% |
| Mar 31, 2018 | -70.36% |
| Dec 31, 2017 | -498.82% |
| Sep 30, 2017 | 86.67% |
| Jun 30, 2017 | -329.39% |
| Mar 31, 2017 | -222.95% |